This product is currently not available for purchase.


Women's Recovering from Anorexia Nervosa. Edition No. 1

  • ID: 1915600
  • March 2010
  • 204 Pages
  • VDM Publishing House
1 of 3

This feminist grounded theory study explains the process of recovery from the perspectives of twelve Canadian women. Interviews with these women were analyzed to uncover basic processes of increased awareness of feelings and goals, ability to differentiate own needs while in relationships with others, and capacity to manage uncomfortable emotions. Women strive to overcome not knowing myself (being controlled, feeling uneasy, and constantly comparing self to others) and losing myself to the anorectic obsession (being lured by the eating disorder, letting it take over, and hiding it from others). At a turning point, finding me, women begin to see the eating disorder as a problem and accept responsibility for recovery. They practise taking care of myself by working through both eating and non-eating issues, developing positive self concept, and gaining support from others. In celebrating myself, women overcome vulnerabilities that allowed the anorexia nervosa to develop in the first place. They invest in relationships that meet their needs, adopting a more compassionate informed acceptance toward self and the world. These findings provide a general resource for women and clinicians.

Note: Product cover images may vary from those shown
2 of 3

Kathryn, Weaver.
Dr. Kathryn Weaver, University of New Brunswick counsels women and adolescents suffering from eating disorders. She is principal investigator of the film Through True Eyes: Recovery from Eating Disorders produced by Atlantic Mediaworks, Fredericton, NB, Canada (2009) and is currently researching university women’s experiences with eating issues.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown



Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S